Table 2.
Relative expression of nAChR subunits protein (fold) in breast cancer cell lines compared with normal cell line HS578BST.
| Cell Lines | nAChR Subunits (Protein Level) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Name | α3 | α4 | α5 | α6 | α7 | α9 | α10 | β2 | β3 | β4 |
| MDA-MB-453 | ns | ns | ns | ns | ns | ns | ns | ns | ns | ns |
| BT-549 | ns | ns | ns | ns | ns | +++ | ns | ns | ns | ns |
| MDA-MB-361 | ns | + | + | ns | ns | +++ | ns | ns | ns | ns |
| HS578T | ns | ns | ns | ns | ns | +++ | ns | ns | +++ | ns |
| Bcap-37 | ns | ns | ns | ns | ns | +++ | ns | ns | ++ | ns |
| HCC1395 | ns | ns | ns | ns | ns | ns | ns | ns | ns | ns |
| BT-483 | ns | ns | +++ | ++ | + | +++ | ns | ns | +++ | ns |
| SK-BR-3 | ns | + | + | ns | ns | +++ | ns | ns | ns | + |
| BT-20 | ns | ++ | + | + | ++ | +++ | ns | ns | +++ | ns |
| ZR-75-30 | ++ | + | ++ | + | + | +++ | +++ | ++ | ns | ++ |
| HCC1806 | +++ | +++ | +++ | +++ | ns | +++ | ++ | ns | ++ | ns |
| MCF-7 | ns | ns | ns | ns | ns | +++ | ++ | ns | ns | ns |
| AU565 | +++ | +++ | +++ | +++ | +++ | +++ | +++ | ++ | ns | +++ |
| HCC1937 | +++ | ns | ns | ns | ns | +++ | ns | ns | ++ | ns |
| MDA-MB-231 | ++ | ++ | ns | ns | ++ | +++ | ns | ns | ns | ++ |
| MDA-MB-157 | +++ | +++ | ++ | +++ | +++ | +++ | +++ | ns | +++ | +++ |
| BT474 | +++ | ns | ++ | ns | + | +++ | ns | ns | ++ | + |
| HS578BST | − | − | − | − | − | − | − | − | − | |
Comparisons of differently expressed of nAChRs in normal control cells (HS578BST) and breast cancer cells. +, ++ and +++ represent upregulation of expression (p < 0.05, 0.01 and 0.001, respectively); ns represented no significant difference.